Zydus Cadila, An Innovative, Global Pharmaceutical Company, Has Received Tentative Approval From The Us Fda To Market Droxidopa Capsules, (Us Rld: Northera) In The Strengths Of 100 Mg, 200 Mg, And 300 Mg.Droxidopa Is Used To Treat Symptoms Of Low Blood Pressure When Standing, Caused By A Certain Medical Condition (Neurogenic Orthostatic Hypotension-Noh). This Medication Can Lessen Symptoms Of Low Blood Pressure When Standing (Orthostatic Hypotension), Such As Dizziness And Lightheadedness.The Drug Will Be Manufactured At The Group&Rsquo;S Manufacturing Facility At Sez, Ahmedabad.The Group Now Has 290 Approvals And Has So Far Filed Over 386 Andas Since The Commencement Of The Filing Process In Fy 2003-04.Zydus Cadila Is An Innovative, Global Pharmaceutical Company That Discovers, Develops, Manufactures And Markets A Broad Range Of Healthcare Therapies. The Group Employs Nearly 25,000 People Worldwide And Is Dedicated To Creating Healthier Communities Globally.
